Purebread Brands (BRED.V): The best thing since sliced bread got crap
Voyageur Pharmaceuticals (VM) took a mine and turned it into a pharma company
Can your phone confirm you have strep throat? Light AI (ALGO.E) says yes
Prospera Energy (PEI.V)’s big corporate evolution: From incompetence to dishonesty
Brera Holdings (BREA.Q) pioneering pubco sports investment model, but is it a win?
“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming
Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain.
Read full article here: https://equity.guru/2021/07/acorda-therapeutics-acor-q-taking-pills-in-inbrija-announces-agreement-to-commercialize-parkinsons-treatment-in-spain/
